About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

Luye Pharma’s Investigational Analgesic LY03014 Reaches Endpoints in a Phase I Clinical Trial in China

News

Shanghai, May 10, 2022 - Luye Pharma Group announced today that its investigational drug LY03014, designated as a “Class 1 New Drug” in China, has reached the endpoints in a Phase I clinical trial. Developed on Luye Pharma’s New ...

May 10,2022

Marketing Authorization Application for Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch Accepted in China

Shanghai, China, April 12, 2022 — Luye Pharma Group announced today that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted the Marketing Authorization Application (MAA) ...

April 12,2022

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company